Clear Street’s Biogen BIIB Stock Holding History

Clear Street’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,000	Closed	-$1.29M	–	865
2023 Q3	$1.29M	Buy	+5,000	New	+$1.34M	0.02%	85
2022 Q4	–	Sell	-25,100	Closed	-$6.7M	–	1065
2022 Q3	$6.7M	Buy	+25,100	New	+$5.33M	0.16%	73

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Clear Street's BIIB Position: Q4 2023 in Review

Clear Street sold out of Biogen (BIIB) in Q4 2023, closing a stake of 5,000 shares — an estimated $1.29M sold.

Clear Street first reported a position in BIIB in Q3 2022 and held it in 2 quarters. The position peaked at $6.73M in Q3 2022. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q4 2023.

Clear Street reported no remaining Biogen position as of Q4 2023 after selling out during the quarter.
Clear Street sold 5,000 Biogen shares in Q4 2023, an estimated $1.29M.
Clear Street first reported a position in Biogen in Q3 2022 and held it in 2 quarters.
Clear Street's Biogen position peaked at $6.73M in Q3 2022.
1,002 funds tracked by Wall St. Rank held Biogen as of Q4 2023.

Based on Clear Street's 13F filing for Q4 2023, filed 14 Feb 2024.